PATENT CLAIM ANALYSIS

Application Number: 16178865
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "487000"]

Abstract:
The present invention provides a simple and improved dosage form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 14):
The dosage form of  claim 13 , wherein the cellulose ester comprises at least one of the following grades of cellulose acetate: Cellulose  Hydroxyl Content Acetyl Content Acetate (% by wt.) (% by wt.) Viscosity* Grade 1 8.7 32 2.4 P Grade 2 3.5 39-40, 39.8 \u200938 P Grade 3 7-10 30-36 200-280 sec* Grade 4 3-5 37-43 \u2003\u20026-45 sec* Grade 5 3-5 37-43 100-240 sec* wherein * indicates determination of viscosity as set forth in ASTM D817 (Formula A) and D1343.

Metadata:
- Claim Count in Document: 101.0
- Percentile: 98.0
- Lexical Diversity: 1.47222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15673781', '15680434', '15048743', '15919422', '15919436']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8412772853721632
- 35 USC 102 Novelty (BERT): 0.6202359976778569
- Combined Prediction Score: 0.8191731566027326
- Mean Citation Score: 562.2168720000002
- Max Citation Score: 573.3431
- Similarity Product: 506.0540525158525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test